Stocks in Focus: Tobira Therapeutics (NASDAQ:TBRA), PTC Therapeutics (NASDAQ:PTCT), Johnson & Johnson (NYSE:JNJ), Dex Media (NASDAQ:DXM), Stemline Therapeutics (NASDAQ:STML)
On Monday shares of Tobira Therapeutics, Inc. (NASDAQ:TBRA) closed at $13.97. Tobira Therapeutics, Inc. (NASDAQ:TBRA) announced on 4 May, the completion of its merger with Regado Biosciences, Inc. (NASDAQ: RGDO, through May 4). In conjunction with the closing of theRead More